Literature DB >> 12374194

Carbohydrate structural units in glycosphingolipids as receptors for Gal and GalNAc reactive lectins.

Albert M Wu1.   

Abstract

Glycosphingolipids (GSLs) contain many carbohydrate epitopes or crypto-glycotopes for Gal and GalNAc reactive lectins. Many of them are in the nervous system and function as important receptors in various life processes. During the past two decades, 11 mammalian structural units have been used to express the binding domain of applied lectins. They are: F, GalNAc alpha1 --> 3GalNAc; A, GalNAc alpha1 --> 3Gal; T, Gal beta1 --> 3GalNAc; I, Gal beta1 --> 3GlcNAc; II, Gal beta1 --> 4GlcNAc; B, Gal alpha1 --> 3Gal; E, Gal alpha1 --> 4Gal; L, Gal beta1 --> 4Glc; P, GalNAc beta1 --> 3Gal; S, GalNAc beta1 --> 4Gal, and Tn, GalNAc alpha1 --> Ser(Thr). Although 10 of them occur in GSLs, only 3 (Lbeta, Sbeta, and Tbeta) are found in human brain, and 2 (Lbeta and IIbeta) are present in the inner structures of human blood group active GSLs. In the families of gangliosides, Lbeta and IIbeta represent 55% of the total structural units, while the other three units (Tbeta, Palpha, and Sbeta) constitute the rest. To facilitate the selection of lectins that could serve as structural probes, the carbohydrate binding specificities of Gal/GalNAc reactive lectins have been classified according to their highest affinity for the structural units and their binding properties expressed by decreasing order of reactivity. Hence, the binding relation between GSLs and Gal/GalNAc specific lectins can be established.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12374194     DOI: 10.1023/a:1020263730943

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  67 in total

1.  Lectin activity from embryonic chick brain, heart, and liver: changes with development.

Authors:  D Kobiler; S H Barondes
Journal:  Dev Biol       Date:  1977-10-01       Impact factor: 3.582

2.  Immunohistochemical localization of a beta-galactoside-binding lectin in rat central nervous system. I. Light- and electron-microscopical studies on developing cerebral cortex and corpus callosum.

Authors:  R Joubert; S Kuchler; J P Zanetta; D Bladier; V Avellana-Adalid; M Caron; C Doinel; G Vincendon
Journal:  Dev Neurosci       Date:  1989       Impact factor: 2.984

3.  Immunohistochemical localization of a beta-galactoside-binding lectin in rat central nervous system. II. Light- and electron-microscopical studies in developing cerebellum.

Authors:  S Kuchler; R Joubert; V Avellana-Adalid; M Caron; D Bladier; G Vincendon; J P Zanetta
Journal:  Dev Neurosci       Date:  1989       Impact factor: 2.984

4.  GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy.

Authors:  M Ono; K Handa; S Sonnino; D A Withers; H Nagai; S Hakomori
Journal:  Biochemistry       Date:  2001-05-29       Impact factor: 3.162

5.  Immunochemical studies on the combining site of the blood group A-specific lima bean lectin.

Authors:  S K Sikder; E A Kabat; D D Roberts; I J Goldstein
Journal:  Carbohydr Res       Date:  1986-08-15       Impact factor: 2.104

6.  Differences in lectin reactivities of cellular glycoconjugates between primary human colorectal carcinomas and their metastases.

Authors:  I H Kellokumpu
Journal:  Cancer Res       Date:  1986-09       Impact factor: 12.701

7.  Sugar-specific interaction of bovine brain beta-galactoside-binding lectin with endogenous gangliosides.

Authors:  V M Kannan; P S Appukuttan
Journal:  Indian J Biochem Biophys       Date:  1993-04       Impact factor: 1.918

8.  Analysis of saccharide binding to Artocarpus integrifolia lectin reveals specific recognition of T-antigen (beta-D-Gal(1----3)D-GalNAc).

Authors:  M V Sastry; P Banarjee; S R Patanjali; M J Swamy; G V Swarnalatha; A Surolia
Journal:  J Biol Chem       Date:  1986-09-05       Impact factor: 5.157

9.  Isolation and characterization of an N-acetylgalactosamine specific lectin from Salvia sclarea seeds.

Authors:  V Piller; F Piller; J P Cartron
Journal:  J Biol Chem       Date:  1986-10-25       Impact factor: 5.157

10.  Lectin labeling of sprouting neurons. II. Relative movement and appearance of glycoconjugates during plasmalemmal expansion.

Authors:  K H Pfenninger; M F Maylié-Pfenninger
Journal:  J Cell Biol       Date:  1981-06       Impact factor: 10.539

View more
  6 in total

1.  Glycosylation-related genes are variably expressed depending on the differentiation state of a bioaminergic neuronal cell line: implication for the cellular prion protein.

Authors:  Myriam Ermonval; Daniel Petit; Aurélien Le Duc; Odile Kellermann; Paul-François Gallet
Journal:  Glycoconj J       Date:  2008-10-21       Impact factor: 2.916

2.  Chemoenzymatic synthesis of uridine diphosphate-GlcNAc and uridine diphosphate-GalNAc analogs for the preparation of unnatural glycosaminoglycans.

Authors:  Sayaka Masuko; Smritilekha Bera; Dixy E Green; Michel Weïwer; Jian Liu; Paul L DeAngelis; Robert J Linhardt
Journal:  J Org Chem       Date:  2012-01-12       Impact factor: 4.354

3.  Fine specificity of domain-I of recombinant tandem-repeat-type galectin-4 from rat gastrointestinal tract (G4-N).

Authors:  Albert M Wu; June H Wu; Ming-Sung Tsai; Jia-Hau Liu; Sabine André; Kojiro Wasano; Herbert Kaltner; Hans-Joachim Gabius
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

Review 4.  Lectins as tools in glycoconjugate research.

Authors:  Albert M Wu; Elwira Lisowska; Maria Duk; Zhangung Yang
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

5.  In vivo imaging of Caenorhabditis elegans glycans.

Authors:  Scott T Laughlin; Carolyn R Bertozzi
Journal:  ACS Chem Biol       Date:  2009-12-18       Impact factor: 5.100

6.  The Effect of Fucoidan from the Brown Alga Fucus evanescence on the Activity of α-N-Acetylgalactosaminidase of Human Colon Carcinoma Cells.

Authors:  Irina Bakunina; Oksana Chadova; Olesya Malyarenko; Svetlana Ermakova
Journal:  Mar Drugs       Date:  2018-05-10       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.